全球骨盆重组器材市场

预计到 2030 年全球骨盆重组器材市场规模将达到 3.002 亿美元

全球骨盆重组器械市场规模预计在2024年为2.724亿美元，到2030年将达到3.002亿美元，在2024-2030年的分析期间内，复合年增长率为1.6%。阴道网片是本报告分析的细分市场之一，预计其复合年增长率为1.0%，到分析期结束时将达到9,940万美元。生物网片细分市场在分析期间的复合年增长率预计为2.5%。

美国市场规模估计为 7,420 万美元，中国市场预计复合年增长率为 3.0%

美国骨盆重组器材市场规模预计2024年达到7,420万美元。预计到2030年，作为世界第二大经济体的中国市场规模将达到5,460万美元，在2024-2030年的分析期内，复合年增长率为3.0%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为0.7%和1.4%。在欧洲，预计德国市场的复合年增长率约为0.9%。

全球骨盆重组设备市场－主要趋势与驱动因素摘要

随着人口结构的变化和意识的增强，为什么骨盆重组设备的需求会增加？

骨盆底重组器械是用于骨盆器官脱垂(POP)、骨盆骨折和其他骨盆底疾病手术治疗的重要医疗植入和工具。这些疾病的发生率不断上升，尤其是在停经后女性、创伤患者以及接受癌症相关骨盆腔手术的患者中，这加速了全球对骨盆底重组解决方案的需求。人口老化正在推动手术数量增长，尤其是在已开发地区，因为骨盆底功能障碍的风险会随着老龄化增长、多胎妊娠和荷尔蒙变化而显着增加。

随着患者和临床医生对骨盆底健康的认识不断提高，骨盆底疾病的污名化正在逐渐消退，对外科手术的需求也日益增长。腹腔镜和机器人辅助骶骨成形术等微创技术因其併发症率较低、恢復速度较快，也越来越受到传统开放性手术的青睐。这种转变正在影响旨在改善长期疗效和恢復骨盆底完整性的新型器械的应用，包括网状植入、生物移植物、骨板、固定螺丝和组织锚。

材料进步、法律规范和外科手术创新如何影响市场格局？

骨盆重组材料的演变一直是产品创新和监管审查的焦点。合成网片曾是主流，但由于出现糜烂和疼痛的报道，其面临监管压力。因此，该行业正在转向更轻的单丝网片、可吸收材料以及生物衍生移植物，这些材料具有更高的生物相容性，且不利事件更少。製造商目前正在投资具有大孔结构和抗菌涂层的网片设计，以降低感染和纤维化的风险。

在手术方面，机器人辅助手术使骨盆重组更加精准，尤其是在复杂的解剖修復和深层骨盆手术中。 3D影像、术中导航和无缝线固定等技术创新也简化了手术工作流程，改善了解剖对位。美国FDA和欧洲CE标誌管理机构等监管机构正在加强上市前核准和上市后监管要求，这影响了器材开发时间，并提高了市场准入门槛。

为什么性别特定的应用以及整形外科和创伤整合正在创造新的成长途径

虽然骨盆底重建手术通常与女性健康息息相关，但整形外科和创伤外科领域对骨盆骨折固定器械的需求正在增长，无论男性或女性。交通事故、跌倒、运动等造成的高衝击损伤正在增加，尤其是在骨骼较弱的老年人和生活方式更活跃的年轻人中。这两种需求推动了生物可吸收钢板、模组化骶骨螺丝和骨盆固定係统等领域的产品开发，以满足多样化的解剖和外科需求。

在泌尿系统，针对前部、后部和顶端区域脱垂设计的性别特异性植入正日益普及。这些装置经过量身定制，更符合人体解剖学，移位风险更低，植入更直观。结合固定係统、生物网片和病患专用3D列印组件的客製化套件，在骨盆重组量大的外科医师中广受欢迎。在先进的术前规划和模拟技术的推动下，骨盆手术的个人化正在扩大患者可用的重组方案范围。

是什么推动了全球骨盆重组设备市场的成长？

骨盆重组器械市场的成长受到多种因素的推动，包括全球骨盆器官脱垂和创伤性骨盆骨折负担的日益加重，以及微创手术技术的日益普及。关键的成长要素在于临床需求与技术创新的结合，这些创新使得重组手术更加精准、患者友善且疗效更佳。

报销改革、外科培训网络的扩展以及医疗技术公司对女性健康的投资不断增加，正在加速下一代骨盆器械技术的普及。此外，鼓励早期诊断骨盆底疾病和治疗创伤相关损伤的公共卫生措施也增强了对相关手术的需求。随着人口老化、外科手术的标准化以及全球技术的融合，骨盆重组器械市场有望持续创新和成长。

部分

产品类型（阴道网片、生物网膜、合成网片、阴道吊带系统、阴道托）；适应症（骨盆器官脱垂、阴道脱垂、直肠脱垂、尿失禁、间质性膀胱炎、瘻管）；最终用户（医院、门诊手术中心、专科诊所、其他最终用户）

受访公司范例（值得关注的39家公司）

• Betatech Medical
• Boston Scientific Corporation
• Caldera Medical
• Coloplast A/S
• Cook Medical
• CooperSurgical Inc.
• Dipromed Srl
• Ethicon（Johnson & Johnson）
• Integra LifeSciences
• MedGyn Products Inc.
• Medtronic plc
• Neomedic International
• Panpac Medical Corporation
• Promedon
• Serag-Wiessner GmbH & Co. KG
• Smith & Nephew plc
• Stryker Corporation
• TEI Biosciences Inc.
• Zephyr Surgical Implants
• Zimmer Biomet Holdings, Inc.

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口（成品和原始OEM）来预测其竞争地位的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括人为提高销货成本、盈利下降、供应链重组以及其他微观和宏观市场动态。

全球产业分析师密切关注来自全球顶尖首席经济学家（14,949位）、智库（62家）以及贸易和产业协会（171家）的专家的意见，以评估其对生态系统的影响并应对新的市场现实。我们追踪了来自每个主要国家的专家和经济学家对关税及其对本国影响的看法。

全球产业分析师预计，这场动盪将在未来2-3个月内逐渐平息，新的世界秩序将更加清晰地建立。全球产业分析师正在即时追踪这些事态发展。

2025年4月：谈判阶段

在4月的报告中，我们将探讨关税对全球整体市场的影响，并提供区域市场调整。我们的预测是基于历史数据和不断变化的市场影响因素。

2025年7月：最终关税调整

在各国宣布最终重置后，客户将在 7 月收到免费更新，最终更新将包含明确的关税影响分析。

相互和双边贸易及关税影响分析：

美国<>中国<>墨西哥<>加拿大<>欧盟<>日本<>印度<>其他176个国家

领先的产业经济学家：全球产业分析师知识库追踪了 14,949 位经济学家，其中包括来自民族国家、智库、贸易和产业协会、大型企业以及各领域专家的最具影响力的首席经济学家，他们共用了这场前所未有的全球经济状况模式转移的影响。我们超过 16,491 份报告大多遵循基于里程碑的两阶段发布计划。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Pelvic Reconstruction Devices Market to Reach US$300.2 Million by 2030

The global market for Pelvic Reconstruction Devices estimated at US$272.4 Million in the year 2024, is expected to reach US$300.2 Million by 2030, growing at a CAGR of 1.6% over the analysis period 2024-2030. Vaginal Mesh, one of the segments analyzed in the report, is expected to record a 1.0% CAGR and reach US$99.4 Million by the end of the analysis period. Growth in the Biological Mesh segment is estimated at 2.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$74.2 Million While China is Forecast to Grow at 3.0% CAGR

The Pelvic Reconstruction Devices market in the U.S. is estimated at US$74.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$54.6 Million by the year 2030 trailing a CAGR of 3.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.7% and 1.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 0.9% CAGR.

Global Pelvic Reconstruction Devices Market - Key Trends & Drivers Summarized

Why Is the Demand for Pelvic Reconstruction Devices Growing Amid Demographic Shifts and Rising Awareness?

Pelvic reconstruction devices are critical medical implants and tools used in the surgical treatment of pelvic organ prolapse (POP), pelvic fractures, and other pelvic floor disorders. With the rising incidence of these conditions-particularly among postmenopausal women, trauma patients, and individuals undergoing cancer-related pelvic surgeries-the global demand for pelvic reconstruction solutions is accelerating. Aging populations, especially in developed regions, are driving procedural volumes as the risk of pelvic floor dysfunction significantly increases with age, multiparity, and hormonal changes.

Greater awareness of pelvic health among both patients and clinicians is reducing the stigma around pelvic floor disorders and increasing demand for surgical intervention. Minimally invasive techniques, such as laparoscopic and robotic-assisted sacrocolpopexy, are gaining preference over traditional open surgeries due to lower complication rates and faster recovery. These shifts are influencing the adoption of newer device types, including mesh implants, biologic grafts, bone plates, fixation screws, and tissue anchors-all designed to improve long-term outcomes and restore pelvic integrity.

How Are Material Advancements, Regulatory Oversight, and Surgical Innovations Shaping the Market Landscape?

The evolution of materials used in pelvic reconstruction has been a focal point of product innovation and regulatory scrutiny. Synthetic meshes, once the dominant choice, have come under regulatory pressure following reports of erosion and pain. As a result, the industry is pivoting toward lighter, monofilament meshes, absorbable materials, and biologically derived grafts that offer better biocompatibility and fewer adverse events. Manufacturers are now investing in mesh designs with macroporous structures and anti-microbial coatings to reduce infection and fibrosis risks.

On the procedural front, robotic-assisted surgeries are enabling higher precision in pelvic reconstruction, particularly in complex anatomical repairs and deep pelvic procedures. Innovations in 3D imaging, intraoperative navigation, and sutureless fixation are also streamlining surgical workflows and improving anatomical alignment. Regulatory bodies such as the U.S. FDA and European CE mark authorities are tightening pre-market approval and post-market surveillance requirements, influencing device development timelines and raising the barrier to market entry.

Why Are Gender-Specific Applications and Orthopedic-Trauma Integration Creating New Growth Pathways?

While pelvic floor reconstruction is more commonly associated with women’s health, the market for pelvic fracture fixation devices in orthopedic and trauma surgery is growing among both genders. High-impact injuries from road accidents, falls, and sports are increasing, particularly among aging populations with fragile bones and younger individuals with active lifestyles. This dual demand is driving product development in areas such as bioresorbable plates, modular sacral screws, and internal pelvic fixation systems that can accommodate diverse anatomical and surgical needs.

In urogynecology, gender-specific implants designed for anterior, posterior, and apical compartment prolapse are gaining traction. These devices are tailored for better anatomical fit, lower migration risk, and more intuitive implantation. Customizable kits that combine fixation systems with biologic mesh or patient-specific 3D-printed components are becoming popular among high-volume pelvic reconstructive surgeons. This personalization of pelvic surgery, driven by advanced preoperative planning and simulation, is broadening the scope of reconstructive options available to patients.

What’s Driving the Growth of the Pelvic Reconstruction Devices Market Worldwide?

The growth in the pelvic reconstruction devices market is driven by several factors including the increasing global burden of pelvic organ prolapse, trauma-related pelvic fractures, and the expanding adoption of minimally invasive surgical techniques. A key growth driver is the combination of clinical need and technological innovation-enabling more precise, patient-friendly, and outcome-optimized reconstructive procedures.

Reimbursement reforms, growing surgical training networks, and rising investment in women’s health by medtech firms are accelerating the adoption of next-generation pelvic devices. Additionally, public health initiatives that encourage early diagnosis of pelvic floor disorders and trauma-related injury treatment are strengthening procedural demand. With aging demographics, surgical standardization, and technology convergence aligning globally, the pelvic reconstruction devices market is poised for sustained innovation and growth.

SCOPE OF STUDY:

The report analyzes the Pelvic Reconstruction Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems, Vaginal Pessary); Indication (Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse, Urinary Incontinence, Interstitial Cystitis, Fistulae); End-Use (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 39 Featured) -

• Betatech Medical
• Boston Scientific Corporation
• Caldera Medical
• Coloplast A/S
• Cook Medical
• CooperSurgical Inc.
• Dipromed Srl
• Ethicon (Johnson & Johnson)
• Integra LifeSciences
• MedGyn Products Inc.
• Medtronic plc
• Neomedic International
• Panpac Medical Corporation
• Promedon
• Serag-Wiessner GmbH & Co. KG
• Smith & Nephew plc
• Stryker Corporation
• TEI Biosciences Inc.
• Zephyr Surgical Implants
• Zimmer Biomet Holdings, Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Pelvic Reconstruction Devices - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Prevalence of Pelvic Organ Prolapse and Incontinence Disorders Drives Demand for Pelvic Reconstruction Devices
  • Expansion of Urogynecology and Minimally Invasive Pelvic Surgeries Throws the Spotlight on Advanced Mesh Systems
  • OEM Innovation in Lightweight, High-Porosity Implants Enhances Biocompatibility and Long-Term Outcomes
  • Growth in Aging Female Population Globally Strengthens Market for Pelvic Floor Support Devices
  • OEM Development of Absorbable and Partially Absorbable Implants Supports Tissue Integration Strategies
  • Rising Preference for Robot-Assisted and Laparoscopic Approaches Drives Demand for Compatible Device Platforms
  • OEM Focus on Anatomical Customization and Pre-Shaped Meshes Enhances Surgeon Adoption and Patient Comfort
  • Surge in Pessary and Non-Surgical Reconstruction Alternatives Expands Non-Invasive Device Segment
  • OEM Engagement in Post-Surgical Monitoring Systems Enhances Long-Term Treatment Continuity
  • Growth in Awareness Campaigns and Access to Reconstructive Urology Services Fuels Diagnosis Rates
  • OEM Response to Litigation and Mesh Controversies Drives Development of Next-Gen, Safer Materials
  • Increasing Emphasis on Patient-Specific Risk Assessment Spurs Tailored Surgical Planning Tools
  • OEM Collaboration With Pelvic Health Clinics and Teaching Hospitals Strengthens Practitioner Training Programs
  • Expansion of Reimbursement for Female Pelvic Reconstructive Procedures Supports Device Uptake
  • OEM Investment in Surgical Instrument Integration Supports Simplified Implant Deployment Techniques
  • Rising Demand for Daycare Surgeries and Ambulatory Procedures Drives Compact and Rapid Deployment Devices
  • OEM Differentiation Through MRI-Compatible and Radiolucent Materials Enhances Imaging Follow-Up
  • Increasing Use of Patient Reported Outcomes and QOL Metrics Strengthens Evidence-Based Adoption
  • OEM Participation in Pelvic Floor Research Consortia Enhances Cross-Specialty Device Applications
  • Regulatory Emphasis on Clinical Evaluation and Postmarket Safety Enhances Vigilance and Transparency
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Pelvic Reconstruction Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Pelvic Reconstruction Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Pelvic Reconstruction Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Vaginal Mesh by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Vaginal Mesh by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Vaginal Mesh by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Biological Mesh by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Biological Mesh by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Biological Mesh by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Synthetic Mesh by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Synthetic Mesh by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Synthetic Mesh by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Vaginal Sling Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Vaginal Sling Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Vaginal Sling Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Vaginal Pessary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Vaginal Pessary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Vaginal Pessary by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Interstitial Cystitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Interstitial Cystitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Interstitial Cystitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Fistulae by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Fistulae by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Fistulae by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Pelvic Organ Prolapse by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Pelvic Organ Prolapse by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Pelvic Organ Prolapse by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Vaginal Prolapse by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Vaginal Prolapse by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Vaginal Prolapse by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Rectal Prolapse by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Rectal Prolapse by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Rectal Prolapse by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Urinary Incontinence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Urinary Incontinence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Urinary Incontinence by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Pelvic Reconstruction Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 50: USA Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 56: USA Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: USA 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Canada 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• JAPAN
  • Pelvic Reconstruction Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Japan 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• CHINA
  • Pelvic Reconstruction Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 77: China Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• EUROPE
  • Pelvic Reconstruction Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Pelvic Reconstruction Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Pelvic Reconstruction Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• FRANCE
  • Pelvic Reconstruction Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 98: France Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 104: France Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: France 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• GERMANY
  • Pelvic Reconstruction Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: Germany 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 113: Germany Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Germany Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: Germany 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 119: Italy Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Italy Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Italy 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 122: Italy Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Italy Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Italy 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Pelvic Reconstruction Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 125: UK Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 128: UK Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: UK Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: UK 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 131: UK Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: UK Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: UK 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 137: Spain Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Spain Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Spain 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 140: Spain Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Spain Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Spain 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 146: Russia Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Russia Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Russia 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 149: Russia Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Russia Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Russia 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Rest of Europe Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Rest of Europe 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Rest of Europe Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Rest of Europe 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Pelvic Reconstruction Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Pelvic Reconstruction Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Pelvic Reconstruction Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Asia-Pacific Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Asia-Pacific 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Asia-Pacific Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Asia-Pacific 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Pelvic Reconstruction Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 176: Australia Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Australia Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: Australia 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 179: Australia Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Australia Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: Australia 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• INDIA
  • Pelvic Reconstruction Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 182: India Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 185: India Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: India Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: India 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 188: India Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: India Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: India 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 194: South Korea Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: South Korea Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: South Korea 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 197: South Korea Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: South Korea Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: South Korea 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Asia-Pacific Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 206: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Rest of Asia-Pacific Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Rest of Asia-Pacific 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Pelvic Reconstruction Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Pelvic Reconstruction Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Pelvic Reconstruction Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 215: Latin America Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Latin America Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Latin America 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 218: Latin America Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Latin America Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Latin America 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 224: Argentina Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Argentina Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Argentina 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 227: Argentina Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Argentina Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Argentina 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 233: Brazil Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Brazil Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Brazil 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 236: Brazil Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Brazil Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Brazil 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 242: Mexico Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Mexico Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Mexico 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 245: Mexico Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Mexico Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Mexico 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Latin America Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Latin America 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 254: Rest of Latin America Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Latin America Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Rest of Latin America 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Pelvic Reconstruction Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Pelvic Reconstruction Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Pelvic Reconstruction Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 263: Middle East Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Middle East Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Middle East 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 266: Middle East Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Middle East Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Middle East 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 272: Iran Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Iran Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Iran 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 275: Iran Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Iran Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Iran 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 281: Israel Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Israel Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Israel 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 284: Israel Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Israel Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Israel 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Saudi Arabia Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Saudi Arabia 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 293: Saudi Arabia Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Saudi Arabia Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Saudi Arabia 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 299: UAE Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: UAE Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: UAE 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 302: UAE Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: UAE Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: UAE 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Middle East Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Middle East 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Middle East Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Middle East Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Middle East 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• AFRICA
  • Pelvic Reconstruction Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Pelvic Reconstruction Devices by Product Type - Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for Pelvic Reconstruction Devices by Product Type - Percentage Breakdown of Value Sales for Vaginal Mesh, Biological Mesh, Synthetic Mesh, Vaginal Sling Systems and Vaginal Pessary for the Years 2015, 2025 & 2030
  • TABLE 317: Africa Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Africa Historic Review for Pelvic Reconstruction Devices by Indication - Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 319: Africa 15-Year Perspective for Pelvic Reconstruction Devices by Indication - Percentage Breakdown of Value Sales for Interstitial Cystitis, Fistulae, Pelvic Organ Prolapse, Vaginal Prolapse, Rectal Prolapse and Urinary Incontinence for the Years 2015, 2025 & 2030
  • TABLE 320: Africa Recent Past, Current & Future Analysis for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Africa Historic Review for Pelvic Reconstruction Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 322: Africa 15-Year Perspective for Pelvic Reconstruction Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION